Trial · NCT03683173
Promoting Physical Activity in Rural Communities
NCT03683173, Not applicable, Completed, Washington University School of Medicine; results first posted 2024-01-08
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Promoting Physical Activity in Rural Communities. Trials, record NCT03683173. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03683173
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Promoting Physical Activity in Rural Communities
- NCT number
- NCT03683173
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,241 participants, actual
- Lead sponsor
- Washington University School of Medicine
- Conditions
- Physical Activity
- Interventions
- Intervention
- First posted
- 2018-09-25
- Last updated
- 2024-01-08
- Results first posted
- 2024-01-08
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Objective Physical Activity Measured by Accelerometer Measured at Baseline and 18-month Follow-up | Baseline and 18-month follow-up | * Participants will wear an accelerometer to measure physical activity. * The outcome measure will measure the weekly minutes of moderate to vigorous physical activity. * Physical activity was measured using the Freedson Adult cutpoint categories from 1998. Each count was measured every 60 seconds/per minute. * Sedentary: 0-99 counts per minute * Light: 100-1951 counts per minute * Moderate: 1952-5724 counts per minute * Vigorous: 5725-9498 counts per minute * Very vigorous: 9499 and up counts per minute |
| Secondary | Number of Participants Who Met the Subjective Physical Activity Recommendations as Measured by the Global Physical Activity Questionnaire at Baseline and 18-month Follow-up | Baseline and 18-month follow-up. | * Will use the Global Physical Activity Questionnaire to determine the number of participants who met the physical activity recommendations at baseline and at the 18-month follow-up. * The Global Physical Activity Questionnaire measures time spent in vigorous and moderate intensity physical activity in the domains of work, travel, and recreation. Participants will answer yes or no to their involvement in a given intensity (e.g., vigorous or moderate) in a given domain. If the participant answers 'yes' they will be asked on how many days do they partake in the activity, and for how many hours and/or minutes do they partake in the activity. A higher score equates to more physical activity. The range is from 0 minutes per week (no moderate physical activity in a week) to over 150 minutes per week (meeting recommendations) for moderate physical activity, and 0 minutes per week (no vigorous physical activity in a week) to over 75 minutes per week (meeting recommendations). |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Objective Physical Activity Measured by Accelerometer Measured at Baseline and 18-month Follow-up | Baseline and 18-month follow-up | Only 56 participants (28 enrolled in the Multilevel Intervention Arm and 28 enrolled in the Control Arm) had valid data at baseline and at the 18-month follow-up. | minutes per week | MEAN |
| SECONDARY | Number of Participants Who Met the Subjective Physical Activity Recommendations as Measured by the Global Physical Activity Questionnaire at Baseline and 18-month Follow-up | Baseline and 18-month follow-up. | The number of participants analyzed includes only those who completed the questionnaire at the indicated time point. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Objective Physical Activity Measured by Accelerometer Measured at Baseline and 18-month Follow-up | Multilevel Intervention | Baseline | 63.46 | Standard Deviation 84.58 | minutes per week |
| Change in Objective Physical Activity Measured by Accelerometer Measured at Baseline and 18-month Follow-up | Control | Baseline | 96.94 | Standard Deviation 85.32 | minutes per week |
| Change in Objective Physical Activity Measured by Accelerometer Measured at Baseline and 18-month Follow-up | Multilevel Intervention | 18-month follow-up | 74.02 | Standard Deviation 97.63 | minutes per week |
| Change in Objective Physical Activity Measured by Accelerometer Measured at Baseline and 18-month Follow-up | Control | 18-month follow-up | 76.13 | Standard Deviation 72.79 | minutes per week |
| Number of Participants Who Met the Subjective Physical Activity Recommendations as Measured by the Global Physical Activity Questionnaire at Baseline and 18-month Follow-up | Multilevel Intervention | Baseline | 292 | Participants | |
| Number of Participants Who Met the Subjective Physical Activity Recommendations as Measured by the Global Physical Activity Questionnaire at Baseline and 18-month Follow-up | Control | Baseline | 287 | Participants | |
| Number of Participants Who Met the Subjective Physical Activity Recommendations as Measured by the Global Physical Activity Questionnaire at Baseline and 18-month Follow-up | Multilevel Intervention | 18-month follow-up | 118 | Participants | |
| Number of Participants Who Met the Subjective Physical Activity Recommendations as Measured by the Global Physical Activity Questionnaire at Baseline and 18-month Follow-up | Control | 18-month follow-up | 102 | Participants |
Source ClinicalTrials.gov
Participant flow12
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Enrolled and Completed Baseline Survey | STARTED | Multilevel Intervention | 627 | 7 |
| Enrolled and Completed Baseline Survey | STARTED | Control | 614 | 7 |
| Enrolled and Completed Baseline Survey | COMPLETED | Multilevel Intervention | 627 | 7 |
| Enrolled and Completed Baseline Survey | COMPLETED | Control | 614 | 7 |
| Enrolled and Completed Baseline Survey | NOT COMPLETED | Multilevel Intervention | 0 | 0 |
| Enrolled and Completed Baseline Survey | NOT COMPLETED | Control | 0 | 0 |
| Completed Follow-up | STARTED | Multilevel Intervention | 627 | 7 |
| Completed Follow-up | STARTED | Control | 614 | 7 |
| Completed Follow-up | COMPLETED | Multilevel Intervention | 240 | 7 |
| Completed Follow-up | COMPLETED | Control | 238 | 7 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Multilevel Intervention | 5 | 627 |
| Total, all-cause mortality | Control | 4 | 614 |
| Total, other adverse events | Multilevel Intervention | 0 | 627 |
| Total, other adverse events | Control | 0 | 614 |
| Total, serious adverse events | Multilevel Intervention | 0 | 627 |
| Total, serious adverse events | Control | 0 | 614 |
Source ClinicalTrials.gov
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01CA211323 | Multilevel Approaches for Promoting Physical Activity in Rural Communities | BROWNSON, ROSS C | WASHINGTON UNIVERSITY | NATIONAL CANCER INSTITUTE | 2017 to 2021 |
Source NIH RePORTER
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Multilevel Intervention vs Control: deaths from any cause | Trial comparisons |
| Multilevel Intervention vs Control: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03683173
GET https://conductscience.org/api/trials/v1/NCT03683173/registered